{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:03:09Z","timestamp":1772665389537,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jcms.2015.06.025","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T02:55:32Z","timestamp":1435632932000},"page":"1461-1469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Intraindividual comparison of preoperative 99mTc-MDP SPECT\/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw"],"prefix":"10.1016","volume":"43","author":[{"given":"Alexandre T.","family":"Assaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4860-7867","authenticated-orcid":false,"given":"Tomislav A.","family":"Zrnc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chressen C.","family":"Remus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Zustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard E.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Derlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2015.06.025_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcms.2007.06.008","article-title":"\u201cBis-phossy jaws\u201d\u2014high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw","volume":"36","author":"Abu-Id","year":"2008","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joms.2008.12.002","article-title":"Imaging findings in bisphosphonate-related osteonecrosis of jaws","volume":"67","author":"Arce","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib3","first-page":"3917","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies","volume":"33","author":"Assaf","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcms.2015.06.025_bib4","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jcms.2013.07.014","article-title":"Intraoperative efficiency of fluorescence imaging by Visually Enhanced Lesion Scope (VELscope\u00ae) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ)","volume":"42","author":"Assaf","year":"2014","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib6","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2015.06.025_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncponc1000","article-title":"Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle","volume":"4","author":"Bertoldo","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.jcms.2015.06.025_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0266-4356(94)90024-8","article-title":"A\u00a0comparison of different imaging modalities and direct inspection after periosteal stripping in predicting the invasion of the mandible by oral squamous cell carcinoma","volume":"32","author":"Brown","year":"1994","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","article-title":"Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws","volume":"35","author":"Chiandussi","year":"2006","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.jcms.2015.06.025_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-011-1429-y","article-title":"Safety of ZA and incidence of ONJ during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II\/III breast cancer","volume":"127","author":"Coleman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jcms.2015.06.025_bib11","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1105195","article-title":"Breast-cancer adjuvant therapy with zoledronic acid","volume":"365","author":"Coleman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcms.2015.06.025_bib12","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jcms.2015.06.025_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.107.048785","article-title":"Bone scintigraphy and SPECT\/CT of bisphosphonate-induced osteonecrosis of the jaw","volume":"50","author":"Dore","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcms.2015.06.025_bib14","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/SCS.0b013e3182902b91","article-title":"Clinical and image findings in bisphosphonate-related osteonecrosis of the jaws","volume":"24","author":"Farias","year":"2013","journal-title":"J\u00a0Craniofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","article-title":"Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonate treatment","volume":"32","author":"Ficarra","year":"2005","journal-title":"J\u00a0Clin Periodontol"},{"key":"10.1016\/j.jcms.2015.06.025_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/11598090-000000000-00000","article-title":"Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumours","volume":"51","author":"Gibiansky","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcms.2015.06.025_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of ONJ in osteoporosis patients receiving 5mg of ZA: data from the health outcomes and reduced incidence with ZA once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jcms.2015.06.025_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00428-006-0261-y","article-title":"Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis \u2013 a paradoxical observation?","volume":"449","author":"Hansen","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jcms.2015.06.025_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2015.06.025_bib20","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/RLU.0b013e31827082f0","article-title":"Role of nuclear medicine imaging in recognizing different causes of osteonecrosis of the jaw","volume":"38","author":"Joshi","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jcms.2015.06.025_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/RLU.0000000000000296","article-title":"Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw","volume":"39","author":"Lapa","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jcms.2015.06.025_bib23","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","article-title":"Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD","volume":"22","author":"Lewiecki","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2015.06.025_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcms.2008.12.004","article-title":"Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction","volume":"37","author":"M\u00fccke","year":"2009","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib26","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.oooo.2012.09.006","article-title":"Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw","volume":"115","author":"Ohbayashi","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2015.06.025_bib27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator","volume":"67","author":"O'Ryan","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/1752-1947-5-477","article-title":"Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: a case report","volume":"5","author":"Otto","year":"2011","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.jcms.2015.06.025_bib30","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.4317\/medoral.19094","article-title":"Alendronate-associated osteonecrosis of the jaws: a review of the main topics","volume":"19","author":"Paiva-Fonseca","year":"2014","journal-title":"Med Oral Pathol Oral Cir Bucal"},{"key":"10.1016\/j.jcms.2015.06.025_bib31","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/theoncologist.2009-0115","article-title":"Bisphosphonates and time to osteonecrosis development","volume":"14","author":"Palaska","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jcms.2015.06.025_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.joms.2009.05.442","article-title":"Tetracycline bone fluorescence: a valuable marker for osteonecrosis characterization and therapy","volume":"68","author":"Pautke","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.joms.2010.07.014","article-title":"Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study","volume":"69","author":"Pautke","year":"2011","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.oraloncology.2011.03.022","article-title":"Bisphosphonate related osteonecrosis of the jaw\u2013manifestation in a microvascular iliac bone flap","volume":"47","author":"Pautke","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2015.06.025_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3174\/ajnr.A0518","article-title":"Imaging findings of bisphosphonate-associated osteonecrosis of the jaws","volume":"28","author":"Phal","year":"2007","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.jcms.2015.06.025_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1208\/s12248-012-9414-x","article-title":"Specific method validation and sample analysis approaches for biocomparability studies of denosumab addressing method and manufacture site changes","volume":"15","author":"Pourvasei","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.jcms.2015.06.025_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/10428190600977690","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients","volume":"48","author":"Pozzi","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcms.2015.06.025_bib38","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.2012.46.4792","article-title":"ONJ and oral health-related quality of life after adjuvant ZA: an adjuvant ZA to reduce recurrence trial subprotocol (BIG01\/04)","volume":"31","author":"Rathbone","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.jcms.2015.06.025_bib39","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1196\/annals.1346.041","article-title":"Bisphosphonates: from bench to bedside","volume":"1068","author":"Russell","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcms.2015.06.025_bib41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1759720X13485829","article-title":"Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions","volume":"5","author":"Ruza","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jcms.2015.06.025_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2214\/ajr.158.1.1727365","article-title":"The scintigraphic diagnosis of osteomyelitis","volume":"158","author":"Schauwecker","year":"1992","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jcms.2015.06.025_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0278-2391(90)90389-J","article-title":"Bone scanning for evaluating mandibular bone extension of oral squamous cell carcinoma","volume":"48","author":"Soderholm","year":"1990","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2015.06.025_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00784-009-0293-1","article-title":"Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study","volume":"14","author":"Stockmann","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jcms.2015.06.025_bib45","first-page":"2464","article-title":"The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis","volume":"87","author":"Termaat","year":"2005","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.jcms.2015.06.025_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jbspin.2007.05.003","article-title":"Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy","volume":"75","author":"Vieillard","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jcms.2015.06.025_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.oooo.2012.08.458","article-title":"Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw","volume":"114","author":"Wilde","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2015.06.025_bib48","first-page":"303","article-title":"Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma","volume":"20","author":"Wilkinson","year":"1979","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcms.2015.06.025_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bone.2013.09.008","article-title":"Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002\u20132012","volume":"57","author":"Wysowski","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2015.06.025_bib50","first-page":"177","article-title":"Jaw uptake of technetium-99 methylene diphosphonate in patients on bisphosphonates: a word of caution","volume":"10","author":"Zanglis","year":"2007","journal-title":"J\u00a0Hell Nucl Med"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518215002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518215002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:33:38Z","timestamp":1760884418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518215002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1010518215002024"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2015.06.025","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraindividual comparison of preoperative 99mTc-MDP SPECT\/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2015.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}